NOS2 and pulmonary hypertension: iNOS, also known as NOS2, catalyzes the production of NO, and a decrease in iNOS results in a reduction in NO content, which in turn leads to pulmonary hypertension and increased pulmonary vascular permeability, exceeding the compensatory capacity of the body, which ultimately leads to HAPE [39].